Ch’ng, Jun-Hong
Sirel, Madle
Zandian, Arash
del Pilar Quintana, Maria
Chun Leung Chan, Sherwin
Moll, Kirsten
Tellgren-Roth, Asa
Nilsson, IngMarie
Nilsson, Peter
Qundos, Ulrika
Wahlgren, Mats
Article History
Received: 3 November 2016
Accepted: 20 January 2017
First Online: 24 February 2017
Competing interests
: MW is a co-founder and board member of Modus Therapeutics AB, a company developing drugs for severe malaria. All other authors declare no financial conflicts of interest.